Skip to content
Peptigraph home

Kisspeptin-10 for Men: Studies and Label Warnings

Studies of Kisspeptin-10 that enrolled only men, what they measured, and what is still unproven.

Medical review pendingGnRH stimulatorUpdated
Strongest evidence
Human RCT
Studies enrolling only men
4
in our evidence file (PubMed search, 11 Oct 2026)
FDA status
Not approved

Studies that enrolled only men

Each row is a study whose participants were described as men only. Results from one sex are not evidence for the other. Studies of animals and cells are not included.

Kisspeptin-10 studies that enrolled only men
StudyDesignPopulationDoseFirst outcome
European journal of endocrinology 2026, PMID 42549827Human RCTHealthy men (3 studies: acute dose-response, 5-day continuous, 12-day intermittent)1.25-10.0 nmol/kg/h acute; 150 nmol/h daily 8 h for 12 daysLH, FSH and testosterone (acute): Acute kisspeptin-10 infusions raised LH, FSH and testosterone dose-dependently versus vehicle (P < .0001).
The Journal of clinical endocrinology and metabolism 2022, PMID 35244717Human RCTHealthy eugonadal men (plus in-vitro human bone cells)Not statedBone formation marker: Total osteocalcin rose a maximum of 20.3% after kisspeptin (P = .021).
The Journal of clinical investigation 2017, PMID 28112678Human RCTHealthy heterosexual young menNot statedLimbic brain activity and mood: Kisspeptin enhanced limbic brain activity in response to sexual and couple-bonding stimuli.
The Journal of clinical endocrinology and metabolism 2011, PMID 21632807Human controlled trialHealthy men (n=4 to 6 per dose group)iv bolus 0.01-3.0 ug/kg; infusion 1.5-4 ug/kg/hTestosterone during infusion: At 4 ug/kg/h for 22.5 h, LH rose from 5.4 to 20.8 IU/liter and testosterone from 16.6 to 24.0 nmol/liter.

Peptides studied in men, compared

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Men's health context

MedlinePlus lists low testosterone among conditions that affect only men.[14]

Studies that enrolled only men

In healthy men, kisspeptin-10 given as an intravenous bolus produced a dose-dependent rise in LH, and a 3 μg/kg bolus gave a smaller response than 1 μg/kg.[4]

Subcutaneous kisspeptin-10 infusion raised testosterone in healthy men, and the gonadotropin rises were sustained for 12 days.[1]

In healthy heterosexual young men, kisspeptin increased limbic brain activity to sexual and bonding stimuli and lowered negative mood.[3]

In healthy men with normal testosterone, short-term kisspeptin exposure increased a bone-formation marker without raising resorption markers.[2]

What is missing

A PubMed search on 2 Oct 2026 for kisspeptin with men, male, testosterone or hypogonadism words in humans returned 90 records, but all the male studies cached here enrolled healthy men and none a hypogonadal population.

Calculated from source web/src/data/evidence/kisspeptin.json searches; date 2026-10-02; query kisspeptin[tiab] AND humans[mh] AND (men[tiab] OR male[tiab]) AND (testosterone[tiab] OR hypogonadism[tiab]); count 90; cached male studies 4; hypogonadal cached 0. Formula: count reported as recorded

Other peptides people research for men

All peptides for men, compared

Common questions

Has Kisspeptin-10 been studied in men?

4 studies we summarise enrolled only men. Results from one sex are not evidence for the other.

Is Kisspeptin-10 approved for men?

No. Kisspeptin-10 is not FDA approved for any use in men or anyone else.

What is the kisspeptin dosage for men?

No label or approved dosage exists; the studies used per-kilogram or hourly infusion amounts in healthy men, with subcutaneous infusions of 1.25 to 10.0 nmol/kg/h in the dose-response arm.[1]

More on Kisspeptin-10

Sources

  1. 1Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men.European journal of endocrinology · 2026PMID 42549827Accessed 2 Oct 2026
  2. 2Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.The Journal of clinical endocrinology and metabolism · 2022PMID 35244717Accessed 2 Oct 2026
  3. 3Kisspeptin modulates sexual and emotional brain processing in humans.The Journal of clinical investigation · 2017PMID 28112678Accessed 2 Oct 2026
  4. 4Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men.The Journal of clinical endocrinology and metabolism · 2011PMID 21632807Accessed 2 Oct 2026
  5. 5PubMed search: ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab]) AND humans[mh] (110 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: (kisspeptin[tiab]) AND humans[mh] AND (randomized controlled trial[pt] OR clinical trial[pt]) (54 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  7. 7PubMed search: kisspeptin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) AND humans[mh] (13 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  8. 8PubMed search: kisspeptin[tiab] AND humans[mh] AND (men[tiab] OR male[tiab]) AND (testosterone[tiab] OR hypogonadism[tiab]) (90 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  9. 9PubMed search: kisspeptin[tiab] AND (menopaus*[tiab] OR postmenopaus*[tiab]) (89 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10PubMed search: kisspeptin[tiab] AND (liver[tiab] OR NAFLD[tiab] OR hepatic[tiab]) (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: ("kisspeptin-10"[tiab] OR "kisspeptin-54"[tiab] OR kisspeptin[tiab]) AND humans[mh] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (75 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  12. 12PubMed search: (kisspeptin[tiab]) AND (nausea[tiab] OR flush*[tiab] OR "injection site"[tiab] OR headache[tiab] OR "ovarian hyperstimulation"[tiab] OR tachyphylaxis[tiab] OR desensiti*[tiab]) AND humans[mh] (60 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  13. 13PubMed search: (kisspeptin[tiab] OR "kisspeptin-54"[tiab] OR "kisspeptin-10"[tiab]) AND ("clinical trial"[pt] OR "randomized controlled trial"[pt]) AND (women[tiab] OR men[tiab]) AND (adverse[tiab] OR tolerat*[tiab] OR "side effects"[tiab]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  14. 14Official web pageOfficial web page · web page

Found an error? Report a correction.